Alliance Pharma Plc

Type: Company
Name: Alliance Pharma Plc
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

MARKET REPORT: UK drugs giant GlaxoSmithKline tipped to prey on Raptor

Professional punters on both sides of the Pond were in raptures about Raptor Pharmaceuticals in the US as rumours did the rounds again that the global biopharmaceuticals group’s days of independence are numbered. As its shares climbed $0.39 to $10.69 ... [Published This Is Money - Jul 09 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

Proactive news summary - Roxi Petroleum, Mwana Africa, Ortac, Sula Iron & Gold, Iofina, Summit Corp, Alliance Pharma, Ascent Resources, Providence, Victoria Oil & Gas

Roxi Petroleum ( LON:RXP ) virtually doubled in price after news of a discovery at its flagship BNG asset in Kazakhstan. Results from Mwana Africa ( LON:MWA ) got the thumbs-up early on though gains  were clawed back later. Underlying earnings (EBITDA) ... [Published Proactiveinvestors United Kingdom RSS feed - Jul 09 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 6 reports

Alliance Pharma reveals strong performance from key products

Alliance Pharma, the pharmaceutical company based at Chippenham in Wiltshire, is trading in line with expectations following a strong performance from several key products.The business announced in a pre-close trading update that total turnover including ... [Published Insider Media Limited - Jul 09 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

Alliance Pharma plc’s Add Rating Reaffirmed at Numis Securities Ltd (APH)

Alliance Pharma plc (LON:APH)Separately, analysts at FinnCap reiterated a "hold" rating on shares of Alliance Pharma plc in a research note on Wednesday. They now have a GBX 36.50 ($0.63) price target on the stock. Alliance Pharma plc (LON:APH) opened ... [Published American Banking News - Jul 09 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

Alliance Pharma Says Flat Revenue Met Its Expectations

at 05:08 AM EDT LONDON (Alliance News) - Alliance Pharma PLC Wednesday said revenue in the first half of the year was about GBP22.5 million, almost flat on the GBP22.8 million it made a year earlier, as it expected.... ... [Published Industrial Info Financials - Jul 09 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

BRIEF-Alliance Pharma H1 rev 21.4 mln pounds

7:19am BSTJuly 9 (Reuters) - Alliance Pharma Plc :* H1 revenue 21.4 million stg versus 22.8 million stg year ago* Trading for first half of year has been in line with management's expectations* H1 turnover including share of joint ventures of approximately ... [Published Reuters UK - Jul 09 2014]
First reported Jul 03 2014 - Updated Jul 03 2014 - 1 reports

Preview: Alliance Pharma

Investors will scan speciality drug company Alliance Pharma’s (APH:AIM) trading statement (9 Jul) for news of potential acquisitions. Alliance Pharma specialises in buying the rights to niche pharmaceuticals, a strategy that has seen it build a ... ... [Published Shares Magazine - Jul 03 2014]
First reported Jun 25 2014 - Updated Jun 26 2014 - 1 reports

AIM Notice - 25/06/2014

25/06/2014 - 08:00AMThe London Stock Exchange admits the following securities to trading on AIM:ALPHA RETURNS GROUP PLC ORDINARY SHARES OF 0.01P EACH, FULLY PAID ALLIANCE PHARMA PLC ORDINARY SHARES OF 1P EACH, FULLY PAID EDENVILLE ENERGY PLC ORDINARY ... [Published MoneyAM - Jun 25 2014]
First reported Jun 20 2014 - Updated Jun 20 2014 - 1 reports

Alliance Pharma options exercised

Alliance Pharma has issued 10,492 ordinary shares following the exercise of employee share options.At 8:32am: (LON:APH) Alliance Pharma PLC share price was 0p at 33.5pStory provided by StockMarketWire.com ... [Published MoneyAM - Jun 20 2014]
First reported Jun 19 2014 - Updated Jun 19 2014 - 1 reports

Exercise of Share Options

For immediate release19 June 2014("Alliance" or the "Company") Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that following the exercise of employee share options on 19 June 2014, application has been made by Alliance ... [Published MoneyAM - Jun 19 2014]
First reported May 21 2014 - Updated May 21 2014 - 1 reports

AGM Statement

For immediate release21 May 2014("Alliance" or the "Company")Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, will hold its Annual General Meeting ("AGM") in London later this morning.Michael Gatenby, the Company's Chairman, will ... [Published TrustNet - May 21 2014]
First reported Mar 26 2014 - Updated Mar 27 2014 - 2 reports

UPDATE - Alliance Phama delighted with return to double-digit profit growth

-- adds share price, CEO and broker comment -- Alliance Pharma ( LON:APH ) grew annual profit by more than a tenth but said the growth rate was more than twice that when stripping out the drag of anti-inflammatory steroid Deltacortril. The group's ... [Published Proactiveinvestors United Kingdom website - Mar 26 2014]

Quotes

Alliance Pharma added: "We continue to expect trading performance in 2014 to be in line with our plans, before the positive impact of any further acquisitions. Around £22m of our acquisition bank facility remains undrawn and available to fund opportunities as they arise."
"The recent acquisitions of Lypsyl in the UK and Ireland and Irenat in Germany are performing broadly in line with expectations, with Lypsyl delivering GBP0.5 million sales and Irenat GBP0.4 million sales in the period" it said
The company's pre-close trading update says: "Hydromol continues to grow well, with sales of £3.0 million in the period, 15% higher than in the same period the previous year."
"Following a robust performance in 2013 when Alliance grew revenue to £45.5 million and increased pre-tax profits by 11% to £12.0 million, trading in the first four months of 2014 has been in line with expectations, with revenue of £15.2 million."

More Content

All (37) | News (35) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
MARKET REPORT: UK drugs giant GlaxoSmithKline t... [Published This Is Money - Jul 09 2014]
Proactive news summary - Roxi Petroleum, Mwana ... [Published Proactiveinvestors United Kingdom RSS feed - Jul 09 2014]
Alliance Pharma reveals strong performance from... [Published Insider Media Limited - Jul 09 2014]
Alliance Pharma plc’s Add Rating Reaffirmed at ... [Published American Banking News - Jul 09 2014]
Alliance Pharma Says Flat Revenue Met Its Expec... [Published Industrial Info Financials - Jul 09 2014]
ALLIANCE PHARMA : Says Flat Revenue Met Its Exp... [Published 4 Traders - Jul 09 2014]
Alliance Pharma in line with expectations [Published MoneyAM - Jul 09 2014]
Alliance Pharma steady in latest half year [Published Proactive Investors.co.uk - Jul 09 2014]
Alliance Pharma Says H1 Trading In Line With Ma... [Published RTTNews.com - Jul 09 2014]
BRIEF-Alliance Pharma H1 rev 21.4 mln pounds [Published Reuters UK - Jul 09 2014]
Alliance Pharma PLC : Pre-Close Trading Update [Published Investegate - Jul 09 2014]
Galvan Week Ahead: UK manufacturing boosts Ster... [Published Proactiveinvestors United Kingdom RSS feed - Jul 05 2014]
Corporate takeovers do not threaten UK pharmace... [Published PJ Online - Jul 04 2014]
Preview: Alliance Pharma [Published Shares Magazine - Jul 03 2014]
AIM Notice - 25/06/2014 [Published MoneyAM - Jun 25 2014]
Alliance Pharma options exercised [Published MoneyAM - Jun 20 2014]
Exercise of Share Options [Published MoneyAM - Jun 19 2014]
AGM Statement [Published TrustNet - May 21 2014]
Alliance Pharma welcomes Cook to board [Published Proactiveinvestors United Kingdom RSS feed - Apr 01 2014]
Lloyds Banking Group fall restricts FTSE 100 [Published Proactiveinvestors United Kingdom RSS feed - Mar 26 2014]
Proactive news summary: Alliance Pharma, Servic... [Published Proactiveinvestors United Kingdom RSS feed - Mar 26 2014]
UPDATE - Alliance Phama delighted with return t... [Published Proactiveinvestors United Kingdom website - Mar 26 2014]
Broker spotlight - ITV, Royal Mail, Man Group, ... [Published Proactiveinvestors United Kingdom RSS feed - Mar 26 2014]
Alliance Phama delighted with return to double-... [Published Proactiveinvestors United Kingdom RSS feed - Mar 26 2014]
Wednesday's agenda: Peel Hunt not expecting bad... [Published Proactiveinvestors United Kingdom website - Mar 25 2014]
Week Ahead: Wolseley's growth to be hampered by... [Published Proactiveinvestors United Kingdom RSS feed - Mar 23 2014]
Galvan Week Ahead: UK growth forecasts lifted, ... [Published Proactiveinvestors United Kingdom RSS feed - Mar 22 2014]
CULS Conversion and Additional Listing [Published TrustNet - Dec 02 2013]
AIM Notice - 15/11/2013 [Published TrustNet - Nov 15 2013]
CULS Conversion and Additional Listing [Published TrustNet - Nov 11 2013]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
UPDATE - Alliance Phama delighted with return t... [Published Proactiveinvestors United Kingdom website - Mar 26 2014]
-- adds share price, CEO and broker comment -- Alliance Pharma ( LON:APH ) grew annual profit by more than a tenth but said the growth rate was more than twice that when stripping out the drag of anti-inflammatory steroid Deltacortril. The group's ...
Wednesday's agenda: Peel Hunt not expecting bad... [Published Proactiveinvestors United Kingdom website - Mar 25 2014]
Wednesday sees interims from UK house builder Bellway (LON: BWYA) - part of a sector which has enjoyed a recent boost in market sentiment. Broker Peel Hunt is not expecting any bad news from the firm, given the state of the housing market and the ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.